SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus: into single digits

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: AlienTech who wrote (408)4/28/1998 6:35:00 PM
From: Bruce Olsten   of 1016
 
BigKNY3 posted the following srcip summary on the PFE board today:
____________________________________________

A total of 113,134 New Rxs were written for Viagra during the week ending April 17th
representing a resounding 95% market share. In comparison, 2,071 New Rxs were
written for Lipitor in its second week. IMS spokeswoman said Viagra's New Rxs "were
impressive". Note that the ED market is up 938% since Viagra became available.

Based on various news articles, this is the approximate ED New Rxs in April:

.....4/17/98.....4/10/98...... 4/3/98.....% Change..% Change... Mkt.Sh
.....New Rxs......New Rxs....New Rxs..Prior Week..4/3/98...4/17/98

Viagra..113,134...36,263.........546.......212%.......++......94.4%
MUSE......4,609.....6,716........7,998......-31%......-42%......3.8%
Caverject..1,800.....2,314........2,450......-22%......-27%.....1.5%
Other.......350........468.............555......-25%......-37%......0.3%
ED Market..119,893...45,761....11,549.....162%.....938%...100.0%
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext